Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MELANOMA

OBR Oncology

FDA Approval for TIL Therapy “Real Milestone” That Has Been “Long Time Coming”

Hematology/Oncology April 8th 2024


FDA Greenlights Amtagvi: New Hope for Treating Advanced Melanoma

Dermatology March 4th 2024

Medical Professionals Reference (MPR)

FDA Drug Approval Decisions Expected in February 2024

Hematology/Oncology January 22nd 2024

The New England Journal of Medicine

Case 2-2024: A 57-Year-Old Woman with Melanoma and Fever

Hematology/Oncology January 22nd 2024

Cancer Therapy Advisor

T-VEC Demonstrates Long-Term Efficacy in High-Risk Melanoma

Dermatology October 2nd 2023

Clinical Advances in Hematology & Oncology

Acral Melanoma: Clinical Advances and Hope for the Future

Oncology, Medical August 28th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form